Literature DB >> 22966991

Enhanced depolarization-induced pulmonary vasoconstriction following chronic hypoxia requires EGFR-dependent activation of NAD(P)H oxidase 2.

Charles E Norton1, Brad R S Broughton, Nikki L Jernigan, Benjimen R Walker, Thomas C Resta.   

Abstract

AIMS: Chronic hypoxia (CH) enhances depolarization-induced myofilament Ca(2+) sensitization and resultant pulmonary arterial constriction through superoxide (O(2)(-))-dependent stimulation of RhoA. Because NAD(P)H oxidase (NOX) has been implicated in the development of pulmonary hypertension, we hypothesized that vascular smooth muscle (VSM) depolarization increases NOX-derived O(2)(-) production leading to myofilament Ca(2+) sensitization and augmented vasoconstrictor reactivity following CH. As epidermal growth factor receptor (EGFR) mediates Rac1-dependent NOX activation in renal mesangial cells, we further sought to examine the role EGFR plays in this response.
RESULTS: Vasoconstrictor responses to depolarizing concentrations of KCl were greater in lungs isolated from CH (4 wk, 0.5 atm) rats compared to normoxic controls, and this effect of CH was abolished by the general NOX inhibitor, apocynin. CH similarly augmented KCl-induced vasoconstriction and O(2)(-) generation (assessed using the fluorescent indicator, dihydroethidium) in Ca(2+)-permeabilized, pressurized small pulmonary arteries. These latter responses to CH were prevented by general inhibition of NOX isoforms (apocynin, diphenylene iodonium), and by selective inhibition of NOX 2 (gp91ds-tat), Rac1 (NSC 23766), and EGFR (AG 1478). Consistent with these observations, CH increased KCl-induced EGFR phosphorylation, and augmented depolarization-induced Rac1 activation in an EGFR-dependent manner. INNOVATION: This study establishes a novel signaling axis in VSM linking membrane depolarization to contraction that is independent of Ca(2+) influx, and which mediates myofilament Ca(2+) sensitization in the hypertensive pulmonary circulation.
CONCLUSION: CH augments membrane depolarization-induced pulmonary VSM Ca(2+) sensitization and vasoconstriction through EGFR-dependent stimulation of Rac1 and NOX 2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22966991      PMCID: PMC3619151          DOI: 10.1089/ars.2012.4836

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  69 in total

1.  Zipper-interacting protein kinase induces Ca(2+)-free smooth muscle contraction via myosin light chain phosphorylation.

Authors:  N Niiro; M Ikebe
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

2.  Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS.

Authors:  Shampa Chatterjee; Elizabeth A Browning; NanKang Hong; Kris DeBolt; Elena M Sorokina; Weidong Liu; Morris J Birnbaum; Aron B Fisher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-14       Impact factor: 4.733

3.  Intermittent hypoxia augments pulmonary vascular smooth muscle reactivity to NO: regulation by reactive oxygen species.

Authors:  Charles E Norton; Nikki L Jernigan; Nancy L Kanagy; Benjimen R Walker; Thomas C Resta
Journal:  J Appl Physiol (1985)       Date:  2011-07-14

4.  Chronic hypoxia upregulates pulmonary arterial ASIC1: a novel mechanism of enhanced store-operated Ca2+ entry and receptor-dependent vasoconstriction.

Authors:  Nikki L Jernigan; Lindsay M Herbert; Benjimen R Walker; Thomas C Resta
Journal:  Am J Physiol Cell Physiol       Date:  2011-12-28       Impact factor: 4.249

5.  Potassium channel blocker activates extracellular signal-regulated kinases through Pyk2 and epidermal growth factor receptor in rat cardiomyocytes.

Authors:  S Tahara; K Fukuda; H Kodama; T Kato; S Miyoshi; S Ogawa
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

6.  NFATc3 is required for chronic hypoxia-induced pulmonary hypertension in adult and neonatal mice.

Authors:  R Bierer; C H Nitta; J Friedman; S Codianni; S de Frutos; J A Dominguez-Bautista; T A Howard; T C Resta; L V Gonzalez Bosc
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-09       Impact factor: 5.464

7.  Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice.

Authors:  F E Rey; M E Cifuentes; A Kiarash; M T Quinn; P J Pagano
Journal:  Circ Res       Date:  2001-08-31       Impact factor: 17.367

8.  Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2.

Authors:  Gábor Csányi; Eugenia Cifuentes-Pagano; Imad Al Ghouleh; Daniel J Ranayhossaini; Loreto Egaña; Lucia R Lopes; Heather M Jackson; Eric E Kelley; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2011-04-17       Impact factor: 7.376

9.  Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension.

Authors:  Mo-Jun Lin; George P H Leung; Wei-Min Zhang; Xiao-Ru Yang; Kay-Pong Yip; Chung-Ming Tse; James S K Sham
Journal:  Circ Res       Date:  2004-07-15       Impact factor: 17.367

10.  Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-alpha.

Authors:  Timothy D Le Cras; William D Hardie; Karen Fagan; Jeffrey A Whitsett; Thomas R Korfhagen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-08-01       Impact factor: 5.464

View more
  25 in total

Review 1.  NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation?

Authors:  Joanna Wieczfinska; Milena Sokolowska; Rafal Pawliczak
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

2.  Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.

Authors:  Feng Chen; Xueyi Li; Emily Aquadro; Stephen Haigh; Jiliang Zhou; David W Stepp; Neal L Weintraub; Scott A Barman; David J R Fulton
Journal:  Free Radic Biol Med       Date:  2016-08-03       Impact factor: 7.376

3.  Activation of the EGFR/p38/JNK pathway by mitochondrial-derived hydrogen peroxide contributes to oxygen-induced contraction of ductus arteriosus.

Authors:  Zhigang Hong; Jésus A Cabrera; Saswati Mahapatra; Shelby Kutty; E Kenneth Weir; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2014-06-08       Impact factor: 4.599

4.  Redox regulation of epidermal growth factor receptor signaling during the development of pulmonary hypertension.

Authors:  Olga Rafikova; Ruslan Rafikov; Archana Kangath; Ning Qu; Saurabh Aggarwal; Shruti Sharma; Julin Desai; Taylor Fields; Britta Ludewig; Jason X-Y Yuan; Danny Jonigk; Stephen M Black
Journal:  Free Radic Biol Med       Date:  2016-02-27       Impact factor: 7.376

5.  Calcitonin gene-related peptide hyperpolarizes mouse pulmonary artery endothelial tubes through KATP channel activation.

Authors:  Charles E Norton; Steven S Segal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-15       Impact factor: 5.464

6.  Chronic hypoxia limits H2O2-induced inhibition of ASIC1-dependent store-operated calcium entry in pulmonary arterial smooth muscle.

Authors:  Danielle R Plomaritas; Lindsay M Herbert; Tracylyn R Yellowhair; Thomas C Resta; Laura V Gonzalez Bosc; Benjimen R Walker; Nikki L Jernigan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-03       Impact factor: 5.464

7.  Actin polymerization contributes to enhanced pulmonary vasoconstrictor reactivity after chronic hypoxia.

Authors:  Laura Weise-Cross; Michelle A Sands; Joshua R Sheak; Brad R S Broughton; Jessica B Snow; Laura V Gonzalez Bosc; Nikki L Jernigan; Benjimen R Walker; Thomas C Resta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-26       Impact factor: 4.733

8.  NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice.

Authors:  Juan Manuel Ramiro-Diaz; Carlos H Nitta; Levi D Maston; Simon Codianni; Wieslawa Giermakowska; Thomas C Resta; Laura V Gonzalez Bosc
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-03-08       Impact factor: 5.464

9.  Antioxidant therapy for the treatment of pulmonary hypertension.

Authors:  Yuichiro J Suzuki; Robin H Steinhorn; Mark T Gladwin
Journal:  Antioxid Redox Signal       Date:  2013-02-28       Impact factor: 8.401

10.  Mechanisms of NFATc3 activation by increased superoxide and reduced hydrogen peroxide in pulmonary arterial smooth muscle.

Authors:  Juan Manuel Ramiro-Diaz; Wieslawa Giermakowska; John M Weaver; Nikki L Jernigan; Laura V Gonzalez Bosc
Journal:  Am J Physiol Cell Physiol       Date:  2014-08-27       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.